Seeing Is Believing
Currently out of the existing stock ratings of Carter Gould, 105 are a BUY (54.4%), 65 are a HOLD (33.68%), 23 are a SELL (11.92%).
Analyst Carter Gould works at BARCLAYS with a stock forecast success ratio of 68.81% fulfilled within 209.27 days on average.
Carter Gould’s has documented 397 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BIIB, Biogen at 04-Apr-2024.
Analyst best performing recommendations are on APLT (APPLIED THERAPEUTICS).
The best stock recommendation documented was for APLT (APPLIED THERAPEUTICS) at 3/21/2022. The price target of $2.5 was fulfilled within 3 days with a profit of $0.67 (36.61%) receiving and performance score of 122.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
195
$25.2 (14.84%)
185
23 days ago
10/12 (83.33%)
$14.65 (8.12%)
191
Buy
189
$19.2 (11.31%)
181
2 months 13 days ago
9/11 (81.82%)
$15.71 (9.07%)
252
Buy
195
$25.2 (14.84%)
180
2 months 13 days ago
9/10 (90%)
$21.71 (12.53%)
445
Hold
165
$-4.8 (-2.83%)
157
3 months 2 days ago
11/11 (100%)
$2.96 (1.83%)
314
Buy
180
$10.2 (6.01%)
195
3 months 16 days ago
3/5 (60%)
$21.06 (13.25%)
496
Which stock is Carter Gould is most bullish on?
Which stock is Carter Gould is most reserved on?
What Year was the first public recommendation made by Carter Gould?